Before taking Paxlovid, consider these drug interactions

FDA and Health Canada recently approved Paxlovid as an oral treatment option for mild-to-moderate COVID-19 who are at high risk of progression to severe COVID-19. It is a combination drug containing nirmatrelvir/ritonavir. Nirmatrelvir works by binding to SARS-CoV-2 3CL protease to ultimately stop viral replication. Ritonavir does not have any antiviral activity against COVID-19 butRead more …Before taking Paxlovid, consider these drug interactions originally appeared inKevinMD.com.

Source: Kevin, M.D. - Medical Weblog - April 7, 2022 Category: General Medicine Authors: < span itemprop="author" > < a href="https://www.kevinmd.com/post-author/param-patel" rel="tag" > Param Patel, PharmD < /a > < /span > Tags: Meds COVID Infectious Disease Medications Source Type: blogs